Ion channels as novel therapeutic targets in heart failure

Annals of Medicine

Volumn 37, Issue 1, 2005, Pages 44-54

  Akar, Fadi G ^a   Tomaselli, Gordon F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmias; Heart failure; Ion channels

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; CALMODULIN; CYCLIC NUCLEOTIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; ION CHANNEL; PHOSPHOLAMBAN; POTASSIUM CHANNEL; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHANNEL; SODIUM PROTON EXCHANGE PROTEIN; SOMATOMEDIN C;

ANIMAL CELL; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DOG; HEART ARRHYTHMIA; HEART AUTOMATICITY; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART REPOLARIZATION; HUMAN; HUMAN CELL; LONG QT SYNDROME; NONHUMAN; PACEMAKER; PATCH CLAMP; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; BIOLOGICAL TRANSPORT, ACTIVE; HEART FAILURE, CONGESTIVE; HUMANS; ION CHANNELS; ION TRANSPORT; VENTRICULAR REMODELING;

EID: 14844300156     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890510007214     Document Type: Review

References (108)

1. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301-6.
2. Forman DE, Rich MW. Heart failure in the elderly. Congest Heart Fail. 2003;9:311-21, discussion 309-10; quiz 322-3.
3. Pedersen OD, Brendorp B, Kober L, Torp-Pedersen C. Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study. Congest Heart Fail. 2003;9:333-40.
4. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993; 88:107-15.
5. Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, et al. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation. 1994;90:2534-9.
6. Estes NA, 3rd, Weinstock J, Wang PJ, Homoud MK, Link MS. Use of antiarrhythmics and implantable cardioverter-defibrillators in congestive heart failure. Am J Cardiol. 2003;91:45D-52D.
7. Chatterjee K. Congestive heart failure: what should be the initial therapy and why? Am J Cardiovasc Drugs. 2002;2:1-6.
8. Kajstura J, Zhang X, Reiss K, Szoke E, Li P, Lagrasta C, et al. Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res. 1994;74:383-400.
9. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res. 1999;42: 270-83.
10. Marban E. Cardiac channelopathies. Nature. 2002;415: 213-8.
11. Akar FG, Rosenbaum DS. Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure. Circ Res. 2003;93:638-45.
12. Janse MJ. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res. 2004;61:208-17.
13. Barry DM, Nerbonne JM. Myocardial potassium channels: electrophysiological and molecular diversity. Annu Rev Physiol. 1996;58:363-94.
14. Antzelevitch C, Yan GX. Cellular and ionic mechanisms responsible for the Brugada syndrome. J Electrocardiol. 2000;33 Suppl.
15. Brooks by P, Levi AJ, Jones JV. The electrophysiological characteristics of hypertrophied ventricular myocytes from the spontaneously hypertensive rat. J Hypertens. 1993;11: 611-22.
16. Ten Eick RE, Zhang K, Harvey RD, Bassett AL. Enhanced functional expression of transient outward current in hypertrophied feline myocytes. Cardiovasc Drugs Ther. 1993;7 Suppl 3:611-9.
17. Beuckelmann DJ, Nabauer M, Erdmann E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 1993;73: 379-85.
18. . 18. Wettwer E, Amos GJ, Posival H, Ravens U. Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ Res. 1994;75:473-82.
19. Nabauer M, Beuckelmann DJ, Uberfuhr P, Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation. 1996;93:168-77.
20. Greenstein JL, Wu R, Po S, Tomaselli GF, Winslow RL. Role of the calcium-independent transient outward current I(to1) in shaping action potential morphology and duration. Circ Res. 2000;87:1026-33.
21. Carmeliet E. K+ channels and control of ventricular repolarization in the heart. Fundam Clin Pharmacol. 1993;7:19-28.
22. Kaab S, Dixon J, Due J, Ashen D, Nabauer M, Beuckelmann DJ, et al. Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation. 1998;98:1383-93.
23. Guo W, Xu H, London B, Nerbonne JM. Molecular basis of transient outward K+ current diversity in mouse ventricular myocytes. J Physiol. 1999;521 Pt 3:587-99.
24. Brahmajothi MV, Campbell DL, Rasmusson RL, Morales MJ, Trimmer JS, Nerbonne JM, et al. Distinct transient outward potassium current (Ito) phenotypes and distribution of fast-inactivating potassium channel alpha subunits in ferret left ventricular myocytes. J Gen Physiol. 1999;113:581-600.
25. Akar FG, Wu RC, Deschenes I, Armoundas AA, Piacentino V 3rd, Houser SR, et al. Phenotypic differences in transient outward K+ current of human and canine ventricular myocytes: insights into molecular composition of ventricular Ito. Am J Physiol Heart Circ Physiol. 2004;286:H602-9.
26. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, et al. Modulation of A-type potassium channels by a family of calcium sensors. Nature. 2000;403:553-6.
27. Rosati B, Pan Z, Lypen S, Wang HS, Cohen I, Dixon JE, et al. Regulation of KChIP2 potassium channel beta subunit gene expression underlies the gradient of transient outward current in canine and human ventricle. J Physiol. 2001;533(Pt 1):119-25.
28. Deschenes I, DiSilvestre D, Juang GJ, Wu RC, An WF, Tomaselli GF. Regulation of Kv4.3 current by KChIP2 splice variants: a component of native cardiac I(to)? Circulation. 2002;106:423-9.
29. Deschenes I, Tomaselli GF. Modulation of Kv4.3 current by accessory subunits. FEBS Lett. 2002;528:183-8.
30. Wible BA, Yang Q, Kuryshev YA, Accili EA, Brown AM. Cloning and expression of a novel K+ channel regulatory protein, KChAP. J Biol Chem. 1998;273:11745-51.
31. Yang EK, Alvira MR, Levitan ES, Takimoto K. Kvbeta subunits increase expression of Kv4.3 channels by interacting with their C termini. J Biol Chem. 2001;276:4839-44.
32. Kaab S, Dixon J, Due J, Nabauer M, Beuckelmann DJ, Steinbeck G, et al. Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation. 1998;98:1383-93.
33. Nabauer M, Kaab S. Potassium channel down-regulation in heart failure. Cardiovasc Res. 1998;37:324-34.
34. Akar FG, Xiong W, Juang GJ, Tian Y, DiSilvestre D, Tomaselli GF. Molecular mechanisms underlying potassium current down-regulation in heart failuire. Circulation. 2003;108:82.
35. Bril A, Landais L, Gout B. Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo. Cardiovasc Drugs Ther. 1993;7:233-40.
36. Kleiman RB, Houser SR. Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol. 1989;256:H1450-61.
37. Cerbai E, Barbieri M, Li Q, Mugelli A. Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages. Cardiovasc Res. 1994;28:1180-7.
38. Ryder KO, Bryant SM, Hart G. Membrane current changes in left ventricular myocytes isolated from guinea pigs after abdominal aortic coarctation. Cardiovasc Res. 1993;27:1278-87.
39. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res. 1996;78:262-73.
40. Rozanski GJ, Xu Z, Whitney RT, Murakami H, Zucker IH. Electrophysiology of rabbit ventricular myocytes following sustained rapid ventricular pacing. J Mol Cell Cardiol. 1997;29:721-32.
41. Li GR, Lau CP, Ducharme A, Tardif JC, Nattel S. Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am J Physiol Heart Circ Physiol. 2002;283:H1031-41.
42. Koumi S, Backer CL, Arentzen CE. Characterization of inwardly rectifying K+ channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Circulation. 1995;92:164-74.
43. Miake J, Marban E, Nuss HB. Biological pacemaker created by gene transfer. Nature. 2002;419:132-3.
44. Warren M, Guha PK, Berenfeld O, Zaitsev A, Anumonwo JM, Dhamoon AS, et al. Blockade of the inward rectifying potassium current terminates ventricular fibrillation in the guinea pig heart. J Cardiovasc Electrophysiol. 2003;14:621-31.
45. Jalife J, Anumonwo JM, Berenfeld O. Toward an understanding of the molecular mechanisms of ventricular fibrillation. J Interv Card Electrophysiol. 2003;9:119-29.
46. Furukawa T, Myerburg RJ, Furukawa N, Kimura S, Bassett AL. Metabolic inhibition of ICa,L and IK differs in feline left ventricular hypertrophy. Am J Physiol. 1994;266:H1121-31.
47. Choy A-M, Kuperschmidt S, Lang CC, Pierson RN, Roden DM. Regional expression of HERG and KvLQT1 in heart failure. Circulation. 1996;94:164.
48. Koumi SI, Martin RL, Sato R. Alterations in ATP-sensitive potassium channel sensitivity to ATP in failing human hearts. Am J Physiol. 1997;272:H1656-65.
49. Kimura S, Bassett AL, Furukawa T, Furukawa N, Myerburg RJ. Differences in the effect of metabolic inhibition on action potentials and calcium currents in endocardial and epicardial cells. Circulation. 1991;84:768-77.
50. O'Rourke B. Myocardial K(ATP) channels in preconditioning. Circ Res. 2000;87:845-55.
51. Baruscotti M, Difrancesco D. Pacemaker Channels. Ann N Y Acad Sci. 2004;1015:111-21.
52. Cerbai E, Pino R, Porciatti F, Sani G, Toscano M, Maccherini M, et al. Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes from human failing heart. Circulation. 1997;95:568-71.
53. Hoppe UC, Jansen E, Sudkamp M, Beuckelmann DJ. Hyperpolarization- activated inward current in ventricular myocytes from normal and failing human hearts. Circulation. 1998;97:55-65.
54. Ludwig A, Zong X, Hofmann F, Biel M. Structure and function of cardiac pacemaker channels. Cell Physiol Biochem. 1999;9:179-86.
55. Cerbai E, Barbieri M, Mugelli A. Occurrence and properties of the hyperpolarization-activated current If in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation. 1996;94:1674-81.
56. Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol. 2002;34:951-69.
57. Hasenfuss G, Meyer M, Schillinger W, Preuss M, Pieske B, Just H. Calcium handling proteins in the failing human heart. Basic Res Cardiol. 1997;92:87-93.
58. Luo CH, Rudy Y. A dynamic model of the cardiac ventricular action potential. II. Afterdepolarizations, triggered activity, and potentiation. Circ Res. 1994;74:1097-113.
59. Richard S, Leclercq F, Lemaire S, Piot C, Nargeot J. Ca2+ currents in compensated hypertrophy and heart failure. Cardiovasc Res. 1998;37:300-11.
60. Balke CW, Shorofsky SR. Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc Res. 1998;37:290-9.
61. Hill JA. Electrical remodeling in cardiac hypertrophy. Trends Cardiovasc Med. 2003;13:316-22.
62. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85:1046-55.
63. Ouadid H, Albat B, Nargeot J. Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol. 1995;25:282-91.
64. Takahashi T, Allen PD, Lacro RV, Marks AR, Dennis AR, Schoen FJ, et al. Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest. 1992;90:927-35.
65. Piot C, Lemaire S, Albat B, Seguin J, Nargeot J, Richard S. High frequency-induced upregulation of human cardiac calcium currents. Circulation. 1996;93:120-8.
66. Beuckelmann DJ, Nabauer M, Erdmann E. Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol. 1991;23:929-37.
67. Schroder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L, et al. Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation. 1998;98:969-76.
68. Hullin R, Asmus F, Ludwig A, Hersel J, Boekstegers P. Subunit expression of the cardiac L-type calcium channel is differentially regulated in diastolic heart failure of the cardiac allograft. Circulation. 1999;100:155-63.
69. Gidh-Jain M, Huang B, Jain P, el-Sherif N. Differential expression of voltage-gated K+ channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ Res. 1996;79:669-75.
70. Nuss HB, Houser SR. T-type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res. 1993;73:777-82.
71. Clozel JP, Ertel EA, Ertel SI. Voltage-gated T-type Ca2+ channels and heart failure. Proc Assoc Am Physicians. 1999;111:429-37.
72. Fares N, Gomez JP, Potreau D. T-type calcium current is expressed in dedifferentiated adult rat ventricular cells in primary culture. C R Acad Sci III. 1996;319:569-76.
73. Leuranguer V, Monteil A, Bourinet E, Dayanithi G, Nargeot J. T-type calcium currents in rat cardiomyocytes during post-natal development: contribution to hormone secretion. Am J Physiol Heart Circ Physiol. 2000;279:H2540-8.
74. Wang HS, Cohen IS. Calcium channel heterogeneity in canine left ventricular myocytes. J Physiol. 2003;547:825-33.
75. Winslow RL, Rice J, Jafri S, Marban E, O'Rourke B. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. Circ Res. 1999;84:571-86.
76. Levine BA, Patchell VB, Sharma P, Gao Y, Bigelow DJ, Yao Q, et al. Sites on the cytoplasmic region of phospholamban involved in interaction with the calcium-activated ATPase of the sarcoplasmic reticulum. Eur J Biochem. 1999;264:905-13.
77. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 1995;92:778-84.
78. Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation. 2000;102:2713-9.
79. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 1993;72:463-9.
80. O'Rourke B, Kass DA, Tomaselli GF, Kaab S, Tunin R, Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ Res. 1999;84:562-70.
81. Ohizumi Y, Sasaki S, Shibusawa K, Ishikawa K, Ikemoto F. Stimulation of sarcoplasmic reticulum Ca(2+)-ATPase by gingerol analogues. Biol Pharm Bull. 1996;19:1377-9.
82. Frank KF BB, Brixius K, Kranias EG, Schwinger RH. Modulation of SERCA: implications for the failing human heart. Basic Res Cardiol. 2002;97(Suppl):I72-8.
83. del Monte F, Hajjar RJ, Harding SE. Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure. Circ Res. 2001;88:E66-7.
84. del Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ. Targeting phospholamban by gene transfer in human heart failure. Circulation. 2002;105:904-7.
85. McKenna E, Smith JS, Coll KE, Mazack EK, Mayer EJ, Antanavage J, et al. Dissociation of phospholamban regulation of cardiac sarcoplasmic reticulum Ca2+ATPase by quercetin. J Biol Chem. 1996;271:24517-25.
86. Bers DM, Pogwizd SM, Schlotthauer K. Upregulated Na/Ca exchange is involved in both contractile dysfunction and arrhythmogenesis in heart failure. Basic Res Cardiol. 2002;97 Suppl 1:I36-42.
87. Winslow RL, Rice J, Jafri S, Marban E, O'Rourke B. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. Circ Res. 1999;84:571-86.
88. Houser SR, Piacentino V, 3rd, Mattiello J, Weisser J, Gaughan JP. Functional properties of failing human ventricular myocytes. Trends Cardiovasc Med. 2000; 10:101-7.
89. Sipido KR, Volders PG, Vos MA, Verdonck F. Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res. 2002;53:782-805.
90. Hobai IA, Maack C, O'Rourke B. Partial Inhibition of Sodium/Calcium Exchange Restores Cellular Calcium Handling in Canine Heart Failure. Circ Res. 2004;95:292-9.
91. Hobai IA, O'Rourke B. The potential of Na+/Ca2+ exchange blockers in the treatment of cardiac disease. Expert Opin Investig Drugs. 2004;13:653-64.
92. Mattiello JA, Margulies KB, Jeevanandam V, Houser SR. Contribution of reverse-mode sodium-calcium exchange to contractions in failing human left ventricular myocytes. Cardiovasc Res. 1998;37:424-31.
93. Zhang T, Miyamoto S, Brown JH. Cardiomyocyte calcium and calcium/calmodulin-dependent protein kinase II: friends or foes? Recent Prog Horm Res. 2004;59:141-68.
94. Kirchhefer U, Schmitz W, Scholz H, Neumann J. Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc Res. 1999;42:254-61.
95. Maier LS, Bers DM. Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J Mol Cell Cardiol. 2002;34:919-39.
96. Lokuta AJ, Rogers TB, Lederer WJ, Valdivia HH. Modulation of cardiac ryanodine receptors of swine and rabbit by a phosphorylation-dephosphorylation mechanism. J Physiol. 1995;487:609-22.
97. Huang B, Wang S, Qin D, Boutjdir M, El-Sherif N. Diminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle: role of beta-adrenergic pathway, G(i) protein, phosphodiesterase, and phosphatases. Circ Res. 1999;85:848-55.
98. Boknik P, Fockenbrock M, Herzig S, Knapp J, Linck B, Luss H, et al. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn Schmiedebergs Arch Pharmacol. 2000;362:222-31.
99. Marks AR. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J Mol Cell Cardiol. 2001;33:615-24.
100. Baartscheer A, Schumacher CA, Belterman CN, Coronel R, Fiolet JW. [Na+] i and the driving force of the Na+/Ca2+-exchanger in heart failure. Cardiovasc Res. 2003;57:986-95.
101. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation. 1997;96:2038-47.
102. Pu J, Boyden PA. Alterations of Na+ currents in myocytes from epicardial border zone of the infarcted heart. A possible ionic mechanism for reduced excitability and postrepolarization refractoriness. Circ Res. 1997;81:110-9.
103. Undrovinas AI, Maltsev VA, Sabbah HN. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci. 1999;55:494-505.
104. Lingrel JB. Na,K-ATPase: isoform structure, function, and expression. J Bioenerg Biomembr. 1992;24:263-70.
105. Bundgaard H, Kjeldsen K. Human myocardial Na,K-ATPase concentration in heart failure. Mol Cell Biochem. 1996;163/164:277-83.
106. Baartscheer A, Schumacher CA, van Borren MM, Belterman CN, Coronel R, Fiolet JW. Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res. 2003;57:1015-24.
107. Karmazyn M, Sostaric JV, Gan XT. The myocardial Na+/ H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs. 2001;61:375-89.
108. Pogwizd SM. Clinical potential of sodium-calcium exchanger inhibitors as antiarrhythmic agents. Drugs. 2003;63:439-52.